Hematopoietic stem cell transplantation found safe and effective for patients with stiff person spectrum disorder

Posted on: 12 February, 2021

Autologous non-myeloablative hematopoietic stem cell transplantation (HSCT) was safe and effective in a subset of patients with stiff person spectrum disorder (SPSD), according to a small open-label study, published in the December 14 online edition of Neurology.

Source: Neurology Today